Misa Yokoyama
Overview
Explore the profile of Misa Yokoyama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
485
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yokoyama M, Tanuma N, Shibuya R, Shiroki T, Abue M, Yamamoto K, et al.
Int J Oncol
. 2018 Feb;
52(3):881-891.
PMID: 29393401
The majority of cancer cells maintain a high glycolytic activity and an increased lactate production, even in a well oxygenated environment. This phenomenon is known as the Warburg effect. Previous...
2.
Shiroki T, Yokoyama M, Tanuma N, Maejima R, Tamai K, Yamaguchi K, et al.
Cancer Sci
. 2017 Feb;
108(5):931-940.
PMID: 28235245
Recent studies have indicated that increased expression of the M2 isoform of pyruvate kinase (PKM2) is involved in glycolysis and tumor development. However, little is known about the role of...
3.
Maejima R, Tamai K, Shiroki T, Yokoyama M, Shibuya R, Nakamura M, et al.
Int J Oncol
. 2016 Aug;
49(3):887-94.
PMID: 27572291
Semaphorins and their receptors are abnormally expressed in various cancers, but little is known about the expression and function of semaphorin 3E (SEMA3E) and its receptor, plexin D1 (PLXND1), in...
4.
Abue M, Yokoyama M, Shibuya R, Tamai K, Yamaguchi K, Sato I, et al.
Int J Oncol
. 2014 Nov;
46(2):539-47.
PMID: 25384963
Several recent studies have revealed that microRNAs (miRNAs) have a role in carcinogenesis and cancer development, and that it is stably detectable in plasma/serum. The aim of this study was...
5.
Tamai K, Nakamura M, Mizuma M, Mochizuki M, Yokoyama M, Endo H, et al.
Cancer Sci
. 2014 Mar;
105(6):667-74.
PMID: 24673799
Cholangiocarcinoma is an aggressive malignant tumor originating from intrahepatic or extrahepatic bile ducts. Its malignant phenotypes may be assumed by cancer stem cells (CSC). Here, we demonstrate that CD274 (PD-L1),...
6.
Endo H, Shiroki T, Nakagawa T, Yokoyama M, Tamai K, Yamanami H, et al.
PLoS One
. 2013 Oct;
8(10):e77070.
PMID: 24130837
The long non-coding RNA HOTAIR has been reported to be a poor prognostic biomarker in a variety of malignant tumors. However, little is known about the association of HOTAIR with...
7.
Nakagawa T, Endo H, Yokoyama M, Abe J, Tamai K, Tanaka N, et al.
Biochem Biophys Res Commun
. 2013 Jun;
436(2):319-24.
PMID: 23743197
HOTAIR is one of long non-coding RNAs and its expression correlates with the prognosis and metastasis in various cancers. We showed that HOTAIR expression has an important role in the...